drugset / Trial / NCT02433899

Microsurgical Versus Conventional Semilunar Coronally Advanced Flap

NCT02433899

Phase 4 Completed 14 enrolled Fluminense Federal University
RandomizedParallel-groupTriple-blindTreatment

Summary

BACKGROUND: The semilunar coronally repositioned flap (SLCRF) has been used for the treatment of recession defects (GR). Recently a microsusgical (MICRO) has been successfully employed with the procedure apparently resulting in improved results, however, no previous controlled clinical study has evaluated the MICRO SLCRF in comparison with SLCRF performed as originally described (MACRO). The objective of the present study was to compare the clinical outcomes of the MICRO and MACRO SLCRF in the treatment of human GR. METHODS: Fourteen patients, with bilateral Miller class I GR defects were randomly assigned to MICRO or MACRO SLCRF. Clinical parameters, assessed at baseline and 6 months later, included recession height (RECH), recession width (RECW), width of keratinized tissue (WKT), probing depth (PD), clinical attachment level (CAL), pain measurements and esthetic evaluation with the Root Coverage Score (RCS). Inter-measurements differences were analyzed with a Chi-square or a paired t-test, with significance set at α\<0.05.

Timeline

Start
2010-10
Primary completion
2012-04
Completion
2012-04

Drugs

EvaluationDrugModalityDoseRoute
Background Chlorhexidine gluconate Other / unclassified Oral
Background Dexamethasone Small molecule 8 mg
Background Epinephrine Other / unclassified
Background Mepivacaine Other / unclassified 2 %

Indications